Gene · 3428
Papers2,876
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,876
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microenvironment-mediated stem cell fate in periodontal tissue remodeling and repair. | Bioact Mater | 2026 | 41541277 | PubTator, text mining | PubMed |
| A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID. | Nat Immunol | 2026 | 41535626 | PubTator, text mining | PubMed |
| BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis. | Cell Rep Med | 2026 | 41529694 | PubTator, text mining | PubMed |
| HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI. | PLoS Pathog | 2026 | 41529066 | PubTator, text mining | PubMed |
| IFI16 senses and protects stalled replication forks. | Mol Cell | 2026 | 41512859 | PubTator, text mining | PubMed |
| The role of pyroptosis during HIV infection. | Inflamm Res | 2026 | 41504820 | PubTator, text mining | PubMed |
| A bortezomib resistance-related gene signature predicts prognosis, with ARID5B downregulation associated with poor overall survival in multiple myeloma. | Discov Oncol | 2026 | 41493673 | PubTator, text mining | PubMed |
| IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell-mediated immunity. | Breast Cancer Res | 2026 | 41484641 | PubTator, text mining | PubMed |
| FAM135B Deficiency Inhibits Cytotoxic T-cell Activity in Triple-Negative Breast Cancer by Blocking the IFI16-Dependent STING Pathway. | Cancer Immunol Res | 2026 | 41218197 | PubTator, text mining | PubMed |
| Aging hematopoietic system: Mechanisms, disorders, and therapeutic frontiers. | Chin Med J (Engl) | 2026 | 40999561 | PubTator, text mining | PubMed |
| The inflammasome next door: characterizing pyroptosis induction in HCV-infected and uninfected bystander cells in vitro. | Front Cell Infect Microbiol | 2025 | 41797942 | PubTator, text mining | PubMed |
| Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis. | bioRxiv | 2025 | 41783369 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| STING activation by teniposide: a potential direct mechanism beyond cGAS stimulation. | Front Immunol | 2025 | 41550929 | PubTator, text mining | PubMed |
| Differential Expression of IFI16, IL-33 and CD55 Link Potential Common Pathogenic Mechanisms for COVID-19 and Ulcerative Colitis. | J Multidiscip Healthc | 2025 | 41439195 | PubTator, text mining | PubMed |
| GBP1 as a machine learning-prioritized biomarker and therapeutic target for epstein-barr virus-induced clear cell renal cell carcinoma: multi-omics causal validation. | Int J Surg | 2025 | 41376480 | PubTator, text mining | PubMed |
| Multi-omics highlights the impacts of cryptorchidism history on immune microenvironment variation in TGCT. | Discov Oncol | 2025 | 41339568 | PubTator, text mining | PubMed |
| METTL14 Regulates the Expression of Genes Related to Interferon, Interleukin and MHC Class I in Nasopharyngeal Carcinoma Cells. | Cancer Med | 2025 | 41316520 | PubTator, text mining | PubMed |
| Terpenoids modulation of the IFI16-AIM2 interaction for enhanced immune response in lung squamous cell carcinoma and AIM2-dysregulated diseases. | In Silico Pharmacol | 2025 | 41211459 | PubTator, text mining | PubMed |
| Structural insights into the atypical filament assembly of pyrin domain-containing IFI16. | EMBO J | 2025 | 41193640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3428/papers?page=4